Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101)
A thyroid carcinoma cell line, BHT-101, has been established in vitro from a metastatic lymph node deposit in a female patient with a non-hormone producing anaplastic, partly thyroglobulin- and thyroxine (T4)-positive papillary thyroid cancer. The cell population is heterogeneous, containing epithel...
Gespeichert in:
| Veröffentlicht in: | Virchows Archiv. Abteilung B. Zellpathologie 1993-12, Vol.63 (4), p.263-269 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 269 |
|---|---|
| container_issue | 4 |
| container_start_page | 263 |
| container_title | Virchows Archiv. Abteilung B. Zellpathologie |
| container_volume | 63 |
| creator | PALYI, I PETER, I DAUBNER, D VINCZE, B LORINCZ, I |
| description | A thyroid carcinoma cell line, BHT-101, has been established in vitro from a metastatic lymph node deposit in a female patient with a non-hormone producing anaplastic, partly thyroglobulin- and thyroxine (T4)-positive papillary thyroid cancer. The cell population is heterogeneous, containing epithelial-like and fibroblast-like cells, and has a doubling time of 24 h. The cell line is polyploid with hypertetraploid predominance and the karyotype showed trisomies, tetrasomies, pentasomies as well as many marker chromosomes. The majority of the cells are negative or weakly positive for thyroglobulin and thyroxine and estrogen and progesterone receptors are present in the cells. BHT-101 cells produce tumours when injected into immunosuppressed CBA/Ca mice. The cells are sensitive to adriamycin, methotrexate and tamoxifen but not to methimazole (Favistan). The epithelial-like clone 1 and the fibroblast-like clone 3, isolated from the parental line, differed in drug sensitivity. This new cell line is suitable for studying the biology of thyroid carcinoma and for parallel in vivo and in vitro studies of drug activity against thyroid cancer. |
| doi_str_mv | 10.1007/BF02899271 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75771192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75771192</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-ba376951a4e7cab064123cab6adb3cb01e37dd0dd095c76f7d417e7befc64da03</originalsourceid><addsrcrecordid>eNpFkMFLwzAUxnNQ5pxevAs5iKhYfWnTZj26sTlh4GWey2uSukibziRV5l9vh2PCg_fg-_G9j4-QCwYPDEA8TuYQj_M8FuyIDCHhEGUg0hNy6v0HQJqyMR-QwRjynGd8SOzMByxr49eNtuGeyjU6lEE784PBtJaiVVS57p16bb0J5suELW0ritTq717FTY0-GEnDeutao6hEJ41tG6RS1zWtjdX0ZrJYRQzY7Rk5rrD2-ny_R-RtPltNF9Hy9fll-rSMZMJYiEpMRJanDLkWEkvIOIuT_shQlYksgelEKAX95KkUWSUUZ0KLUlcy4wohGZHrP9-Naz877UPRGL_Lg1a3nS9EKgRjedyDd3-gdK33TlfFxpkG3bZgUOwKLf4L7eHLvWtXNlod0H2bvX6119FLrCuHVhp_wLjIE-h__gJp9H_S</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75771192</pqid></control><display><type>article</type><title>Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101)</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>PALYI, I ; PETER, I ; DAUBNER, D ; VINCZE, B ; LORINCZ, I</creator><creatorcontrib>PALYI, I ; PETER, I ; DAUBNER, D ; VINCZE, B ; LORINCZ, I</creatorcontrib><description>A thyroid carcinoma cell line, BHT-101, has been established in vitro from a metastatic lymph node deposit in a female patient with a non-hormone producing anaplastic, partly thyroglobulin- and thyroxine (T4)-positive papillary thyroid cancer. The cell population is heterogeneous, containing epithelial-like and fibroblast-like cells, and has a doubling time of 24 h. The cell line is polyploid with hypertetraploid predominance and the karyotype showed trisomies, tetrasomies, pentasomies as well as many marker chromosomes. The majority of the cells are negative or weakly positive for thyroglobulin and thyroxine and estrogen and progesterone receptors are present in the cells. BHT-101 cells produce tumours when injected into immunosuppressed CBA/Ca mice. The cells are sensitive to adriamycin, methotrexate and tamoxifen but not to methimazole (Favistan). The epithelial-like clone 1 and the fibroblast-like clone 3, isolated from the parental line, differed in drug sensitivity. This new cell line is suitable for studying the biology of thyroid carcinoma and for parallel in vivo and in vitro studies of drug activity against thyroid cancer.</description><identifier>ISSN: 0340-6075</identifier><identifier>ISSN: 0042-6431</identifier><identifier>DOI: 10.1007/BF02899271</identifier><identifier>PMID: 8099464</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Animals ; Biological and medical sciences ; Carcinoma - drug therapy ; Carcinoma - genetics ; Carcinoma - pathology ; Cell Division ; Cell Line ; Chromosome Aberrations ; Doxorubicin - therapeutic use ; Endocrinopathies ; Epithelium - pathology ; Female ; Fibroblasts - pathology ; Humans ; Immunohistochemistry ; Karyotyping ; Lymphatic Metastasis - pathology ; Malignant tumors ; Medical sciences ; Methotrexate - therapeutic use ; Mice ; Mice, Inbred CBA ; Middle Aged ; Neoplasm Transplantation ; Ploidies ; Receptors, Estrogen - analysis ; Receptors, Progesterone - analysis ; Tamoxifen - therapeutic use ; Thyroid Neoplasms - drug therapy ; Thyroid Neoplasms - genetics ; Thyroid Neoplasms - pathology ; Thyroid. Thyroid axis (diseases) ; Tumor Cells, Cultured</subject><ispartof>Virchows Archiv. Abteilung B. Zellpathologie, 1993-12, Vol.63 (4), p.263-269</ispartof><rights>1993 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-ba376951a4e7cab064123cab6adb3cb01e37dd0dd095c76f7d417e7befc64da03</citedby><cites>FETCH-LOGICAL-c311t-ba376951a4e7cab064123cab6adb3cb01e37dd0dd095c76f7d417e7befc64da03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4793092$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8099464$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PALYI, I</creatorcontrib><creatorcontrib>PETER, I</creatorcontrib><creatorcontrib>DAUBNER, D</creatorcontrib><creatorcontrib>VINCZE, B</creatorcontrib><creatorcontrib>LORINCZ, I</creatorcontrib><title>Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101)</title><title>Virchows Archiv. Abteilung B. Zellpathologie</title><addtitle>Virchows Arch B Cell Pathol Incl Mol Pathol</addtitle><description>A thyroid carcinoma cell line, BHT-101, has been established in vitro from a metastatic lymph node deposit in a female patient with a non-hormone producing anaplastic, partly thyroglobulin- and thyroxine (T4)-positive papillary thyroid cancer. The cell population is heterogeneous, containing epithelial-like and fibroblast-like cells, and has a doubling time of 24 h. The cell line is polyploid with hypertetraploid predominance and the karyotype showed trisomies, tetrasomies, pentasomies as well as many marker chromosomes. The majority of the cells are negative or weakly positive for thyroglobulin and thyroxine and estrogen and progesterone receptors are present in the cells. BHT-101 cells produce tumours when injected into immunosuppressed CBA/Ca mice. The cells are sensitive to adriamycin, methotrexate and tamoxifen but not to methimazole (Favistan). The epithelial-like clone 1 and the fibroblast-like clone 3, isolated from the parental line, differed in drug sensitivity. This new cell line is suitable for studying the biology of thyroid carcinoma and for parallel in vivo and in vitro studies of drug activity against thyroid cancer.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Carcinoma - drug therapy</subject><subject>Carcinoma - genetics</subject><subject>Carcinoma - pathology</subject><subject>Cell Division</subject><subject>Cell Line</subject><subject>Chromosome Aberrations</subject><subject>Doxorubicin - therapeutic use</subject><subject>Endocrinopathies</subject><subject>Epithelium - pathology</subject><subject>Female</subject><subject>Fibroblasts - pathology</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Karyotyping</subject><subject>Lymphatic Metastasis - pathology</subject><subject>Malignant tumors</subject><subject>Medical sciences</subject><subject>Methotrexate - therapeutic use</subject><subject>Mice</subject><subject>Mice, Inbred CBA</subject><subject>Middle Aged</subject><subject>Neoplasm Transplantation</subject><subject>Ploidies</subject><subject>Receptors, Estrogen - analysis</subject><subject>Receptors, Progesterone - analysis</subject><subject>Tamoxifen - therapeutic use</subject><subject>Thyroid Neoplasms - drug therapy</subject><subject>Thyroid Neoplasms - genetics</subject><subject>Thyroid Neoplasms - pathology</subject><subject>Thyroid. Thyroid axis (diseases)</subject><subject>Tumor Cells, Cultured</subject><issn>0340-6075</issn><issn>0042-6431</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMFLwzAUxnNQ5pxevAs5iKhYfWnTZj26sTlh4GWey2uSukibziRV5l9vh2PCg_fg-_G9j4-QCwYPDEA8TuYQj_M8FuyIDCHhEGUg0hNy6v0HQJqyMR-QwRjynGd8SOzMByxr49eNtuGeyjU6lEE784PBtJaiVVS57p16bb0J5suELW0ritTq717FTY0-GEnDeutao6hEJ41tG6RS1zWtjdX0ZrJYRQzY7Rk5rrD2-ny_R-RtPltNF9Hy9fll-rSMZMJYiEpMRJanDLkWEkvIOIuT_shQlYksgelEKAX95KkUWSUUZ0KLUlcy4wohGZHrP9-Naz877UPRGL_Lg1a3nS9EKgRjedyDd3-gdK33TlfFxpkG3bZgUOwKLf4L7eHLvWtXNlod0H2bvX6119FLrCuHVhp_wLjIE-h__gJp9H_S</recordid><startdate>199312</startdate><enddate>199312</enddate><creator>PALYI, I</creator><creator>PETER, I</creator><creator>DAUBNER, D</creator><creator>VINCZE, B</creator><creator>LORINCZ, I</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199312</creationdate><title>Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101)</title><author>PALYI, I ; PETER, I ; DAUBNER, D ; VINCZE, B ; LORINCZ, I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-ba376951a4e7cab064123cab6adb3cb01e37dd0dd095c76f7d417e7befc64da03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Carcinoma - drug therapy</topic><topic>Carcinoma - genetics</topic><topic>Carcinoma - pathology</topic><topic>Cell Division</topic><topic>Cell Line</topic><topic>Chromosome Aberrations</topic><topic>Doxorubicin - therapeutic use</topic><topic>Endocrinopathies</topic><topic>Epithelium - pathology</topic><topic>Female</topic><topic>Fibroblasts - pathology</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Karyotyping</topic><topic>Lymphatic Metastasis - pathology</topic><topic>Malignant tumors</topic><topic>Medical sciences</topic><topic>Methotrexate - therapeutic use</topic><topic>Mice</topic><topic>Mice, Inbred CBA</topic><topic>Middle Aged</topic><topic>Neoplasm Transplantation</topic><topic>Ploidies</topic><topic>Receptors, Estrogen - analysis</topic><topic>Receptors, Progesterone - analysis</topic><topic>Tamoxifen - therapeutic use</topic><topic>Thyroid Neoplasms - drug therapy</topic><topic>Thyroid Neoplasms - genetics</topic><topic>Thyroid Neoplasms - pathology</topic><topic>Thyroid. Thyroid axis (diseases)</topic><topic>Tumor Cells, Cultured</topic><toplevel>online_resources</toplevel><creatorcontrib>PALYI, I</creatorcontrib><creatorcontrib>PETER, I</creatorcontrib><creatorcontrib>DAUBNER, D</creatorcontrib><creatorcontrib>VINCZE, B</creatorcontrib><creatorcontrib>LORINCZ, I</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Virchows Archiv. Abteilung B. Zellpathologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PALYI, I</au><au>PETER, I</au><au>DAUBNER, D</au><au>VINCZE, B</au><au>LORINCZ, I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101)</atitle><jtitle>Virchows Archiv. Abteilung B. Zellpathologie</jtitle><addtitle>Virchows Arch B Cell Pathol Incl Mol Pathol</addtitle><date>1993-12</date><risdate>1993</risdate><volume>63</volume><issue>4</issue><spage>263</spage><epage>269</epage><pages>263-269</pages><issn>0340-6075</issn><issn>0042-6431</issn><abstract>A thyroid carcinoma cell line, BHT-101, has been established in vitro from a metastatic lymph node deposit in a female patient with a non-hormone producing anaplastic, partly thyroglobulin- and thyroxine (T4)-positive papillary thyroid cancer. The cell population is heterogeneous, containing epithelial-like and fibroblast-like cells, and has a doubling time of 24 h. The cell line is polyploid with hypertetraploid predominance and the karyotype showed trisomies, tetrasomies, pentasomies as well as many marker chromosomes. The majority of the cells are negative or weakly positive for thyroglobulin and thyroxine and estrogen and progesterone receptors are present in the cells. BHT-101 cells produce tumours when injected into immunosuppressed CBA/Ca mice. The cells are sensitive to adriamycin, methotrexate and tamoxifen but not to methimazole (Favistan). The epithelial-like clone 1 and the fibroblast-like clone 3, isolated from the parental line, differed in drug sensitivity. This new cell line is suitable for studying the biology of thyroid carcinoma and for parallel in vivo and in vitro studies of drug activity against thyroid cancer.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>8099464</pmid><doi>10.1007/BF02899271</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0340-6075 |
| ispartof | Virchows Archiv. Abteilung B. Zellpathologie, 1993-12, Vol.63 (4), p.263-269 |
| issn | 0340-6075 0042-6431 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_75771192 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Animals Biological and medical sciences Carcinoma - drug therapy Carcinoma - genetics Carcinoma - pathology Cell Division Cell Line Chromosome Aberrations Doxorubicin - therapeutic use Endocrinopathies Epithelium - pathology Female Fibroblasts - pathology Humans Immunohistochemistry Karyotyping Lymphatic Metastasis - pathology Malignant tumors Medical sciences Methotrexate - therapeutic use Mice Mice, Inbred CBA Middle Aged Neoplasm Transplantation Ploidies Receptors, Estrogen - analysis Receptors, Progesterone - analysis Tamoxifen - therapeutic use Thyroid Neoplasms - drug therapy Thyroid Neoplasms - genetics Thyroid Neoplasms - pathology Thyroid. Thyroid axis (diseases) Tumor Cells, Cultured |
| title | Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T16%3A44%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Establishment,%20characterization%20and%20drug%20sensitivity%20of%20a%20new%20anaplastic%20thyroid%20carcinoma%20cell%20line%20(BHT-101)&rft.jtitle=Virchows%20Archiv.%20Abteilung%20B.%20Zellpathologie&rft.au=PALYI,%20I&rft.date=1993-12&rft.volume=63&rft.issue=4&rft.spage=263&rft.epage=269&rft.pages=263-269&rft.issn=0340-6075&rft_id=info:doi/10.1007/BF02899271&rft_dat=%3Cproquest_cross%3E75771192%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75771192&rft_id=info:pmid/8099464&rfr_iscdi=true |